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Summary The effects of tumour necrosis factor-a (TNFa) on the growth and DNA synthesis of the human
breast cell line, T47D, were studied. A dose-dependent, reversible inhibition of thymidine incorporation and
cell growth was observed in the range of 0.1 ng ml- I to 100 ng ml- of TNFa. Cell viability was not impaired
in any of the experiments. Flow-cytometric DNA analysis demonstrated that after 24 h exposure to TNFa,
T47D cells accumulated in the GI phase of the cell cycle, and were depleted in the G2/M and S phases,
suggesting a block in the progression of the GI/S transition. The involvement of protein kinases (PK) and
protein phosphatases in TNFa-induced signal transduction was also investigated. A transient and rapid 2-fold
increase in total cellular protein kinase C (PKC) activity was detected after 10min exposure to TNFa. To
study the role of the observed PKC activation in the cytostatic effect ofTNFa, T47D cells were exposed to the
cytokine in the presence of the potent PKC inhibitor, H7. The inhibitory effect of TNFa on thymidine
incorporation was not affected by exposure to H7 at concentrations sufficient to block the stimulation of
thymidine up-take induced by the PKC agonist, phorbol-12-myristate-13-acetate (PMA). The involvement of
other signalling pathways was addressed using the cyclic nucleotide-dependent PK inhibitor, H8; the
calmodulin-dependent PK inhibitor, W7; and the inhibitor of protein phosphatases PPI and PP2B, okadaic
acid. Exposure of T47D cells to these enzyme inhibitors failed to antagonise the inhibition of thymidine
incorporation by TNFa. Taken together, these results indicate that the cytostatic effect of TNFa on T47D cells
occurs at the GI/S transition of the cell cycle, and is mediated by an intracellular pathway which does not
involve the activity of protein kinases C and A, nor protein phosphatases PP1, PP2B.
Tumour necrosis factor-a (TNFa) is a polypeptide which
exerts a variety of biological effects (Balkwill, 1989).
Numerous studies have shown that TNFx inhibits the growth
of various cancer cell lines in vivo by both a cytolytic and a
cytostatic mechanism (Sugarman et al., 1985; Fransen et al.,
1986, Browning & Ribolini, 1989). Previous studies have
indicated that cells which are lysed by TNFa are first blocked
at the postsynthetic G2, M phases of the cell cycle, and that
cells accumulating in S or M phases subsequently undergo
cell death (Darzynkiewicz et al., 1984; Dealtry et al., 1987;
Muro et al., 1991). Several cellular mechanisms have been
proposed to explain the cytolytic effect of TNFa (for review:
Larrick & Wright, 1990). However, little is known of the
cellular mechanisms mediating the reversible cytostatic effect
of this cytokine and the associated signal transduction path-
ways.
Several lines of evidence suggest that protein kinase(s) are
involved in TNFa signal transduction. Although TNFa
rapidly induces serine phosphorylation of a variety of cellular
proteins (Hepburn et al., 1988; Marino et al., 1989; Schutze
et al., 1989; Arrigo, 1990), the protein kinase(s) responsible
for this remain elusive. Protein kinase C (PKC) has been
implicated in several actions of TNFa (Schutze et al., 1990;
Zucali et al., 1990; Elbaz et al., 1991; Sancho & Terranova,
1991); phorbol-myristate-acetate (PMA), a potent PKC
agonist, mimics numerous biological effects of this cytokine.
Nevertheless, PKC activation seems only to simulate the
effects of TNFa in most cases, and does not mediate it
directly (Oka & Arrita, 1991; Ritchie et al., 1991). TNFa also
elevates the level of cAMP in a fibroblast cell line (Zhang et
al., 1988) suggesting a possible involvement of a cAMP-
dependent protein kinase (PKA). However, the involvement
of PKA in TNFa-induced protein phosphorylation has yet to
be demonstrated (Pfeilschifter et al., 1991). Calmodulin has
also been implicated in the action of TNFo since free radical
generation induced by this cytokine in human leukocytes is
inhibited by calmodulin antagonists (Das et al., 1990).
In this study the effect ofTNFa on both the DNA synthesis
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and proliferation of the human breast carcinoma cell line,
T47D, was investigated. The involvement of PKC, PKA and
calmodulin-dependent protein kinase (PK-CAM), in the sig-
nal transduction of TNFa was studied using the enzyme-
specific inhibitors H7, H8 and W7 respectively. Cells were
also exposed to the protein phosphatase inhibitor, okadaic
acid (OA), so that the role of protein dephosphorylation in
the signalling could be assessed.
Materials and methods
Cells and reagents
The human ductal breast carcinoma cell line, T47D, was
obtained from the American Type Culture Collection (Rock-
ville, MD, USA). The cell line possesses receptors for oest-
rogens and their growth is supported by oestradiol. The
modal chromosome number of the cells is 65 occurring at
50% of the population. Cells were cultured in RPMI-1640
medium supplemented with 10% foetal calf serum,
0.1 mM ml-' L-glutamine, 10 IUml-1 penicillin and
100mgml-' streptomycin in Nunclon (Nunc, Kamstrup,
Danmark) tissue culture flasks (80 cm2); medium was
changed twice a week. Cells were maintained in log phase by
periodic trypsinisation (0.5 ml/trypsin, 0.2 mg ml-' EDTA in
modified Pucks saline) and subculturing. All tissue culture
reagents were obtained from Gibco (Paisley, UK). Phorbol-
12-myristate-13-acetate (PMA) was purchased from Sigma
(Dorset, UK). H7 (1-(5-isoquinolinesulfonyl)-2-methylpiper-
azin), a potent inhibitor of both PKC and cyclic-nucleotide-
dependent protein kinases (Hidaka et al., 1984) was from
Novabiochem (Nottingham, UK). H8 (N-(1-(methylamino)
ethyl)-5-isoquinolinesulfonamide), an enzyme inhibitor with a
higher affinity for cyclic-nucleotide-dependent protein kinases
(KicGMp = 0.48 jAM; KicAMP = 1.2SAM) than for PKC (Ki =
15 JLM) (Hidaka et al., 1984) was also from Novabiochem
(Nottingham, UK). Okadaic acid, a potent inhibitor of two
(PP1, PPIB) of the three major protein serine/threonine
phosphatases in eukaryotic cells (Cohen et al., 1990), was
from Gibco (Uxbridge, UK). W7 (N-(6-aminohexyl)-5-
chloro-l-naphtalene sulfonamide hydrochloride), a cal-
modulin (CAM) antagonist that inhibits enzyme activities
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regulated by Ca++/CAM (Hidaka et al., 1981), was supplied
by Gibco (Uxbridge, UK). Recombinant human TNFa was
obtained from Genzyme (Boston, MA, USA). Propidium
iodide, colchicine and RNase type A were from Sigma
(Dorset, UK).
Proliferation assays
Cell proliferation was measured in medium-term cultures.
Cells were plated into 6 well Costar culture plates (Cam-
bridge, MA, USA) at low density (3 x 104 cellml-') and
cultured for up to 7 days in the continuous presence of
TNFa and PMA, or a combination of the two. At various
intervals during the culture period, cells were trypsinised,
resuspended in 0.5 ml of PBS, and aliquots counted in trip-
licate in a haemocytometer. All experiments were repeated at
least twice.
DNA synthesis was indirectly assessed by 3H-methyl-5-
thymidine incorporation, and flat-bed scintillation counting
(Potter et al., 1987). Logarithmically growing cells were tryp-
sinised, plated into 96-well Nunc tissue culture plates at a
concentration of 105cell ml-'; each well contained 100jil
medium. Cells were cultured for 24 h before experiments,
then preincubated for 30 min with enzyme inhibitors before
being exposed to TNFa or PMA in the continuous presence
of the inhibitor for various time intervals. In time course
experiments medium was removed after exposure to TNFa
and enzyme inhibitor, cells were washed twice in PBS and
fresh medium added for defined periods. During the last
60 min of incubation, cells were pulse-labelled with 1 jiCi
3H-methyl-thymidine (25 Ci mmol ', Amersham, plc, UK).
Labelling was terminated by washing cells twice in PBS, and
100jil trypsin-EDTA was added for 5 min to detach cells. A
Titertek Skatron Combi cell-harvester was used to transfer
cells from 96-well plate onto a glass fibre filter (1205-401
Printed Filtermat A, Pharmacia, UK). The filters were fixed
in methanol and subsequently air dried, placed in a Betaplate
sample bag (Pharmacia, UK), scintillation liquid (10 ml)
added and the bag heat sealed. Radioactivity was counted in
a LKB 1205 Betaplate liquid scintillation counter.
To check whether thymidine uptake by T47D cells re-
flected genuine DNA synthesis or was perturbed by the
cytoplasmic pooling of 3H-thymidine or its metabolites,
experiments were performed in which DNA was extracted
and purified from cells grown in the presence or absence of
TNFa. Cells in the log phase were cultured in 80 cm2 tissue
culture flasks and pulse-labelled with 10tiCiml-' 3H-
thymidine for 60 min. DNA was extracted by lysing the cells
in 0.2 M NaOH and 1% SDS, and sheared by passing the cell
lysate 15 times rapidly through a 25-gauge needle. DNA was
purified by a silicon-based DNA purification column (Magic
Minipreps, Promega, Madison, USA), which specifically
retains DNA of 1-20 Kb length. The column was washed
with 02. M NaCl, 20 nM Tris pH 7.5, 5 mM EDTA in 50%
ethanol, and DNA eluted with TE buffered preheated to
65-70°C. Purified DNA was dotted onto a positively charged
nylon membrane (Printed nylon membrane 1205-403, Phar-
macia, UK), UV crosslinked and subsequently the radio-
activity counted.
Each experiment was carried out in three replicate wells
and was repeated at least three times. Statistical analysis of
data was performed using the Mann-Whitney U test.
Cell viability after treatments was tested using the trypan
blue exclusion method. Trypsinised cells, as well as cells
floating in the medium, were collected and tested to avoid
positive selection of viable cells attached to the culture plates.
DNAfluorometry
DNA flow-cytometry was performed to investigate the effect
of TNFa on cell cycle progression. Cells were cultured for
24 h in the presence of TNFa, 0.05 mg ml-' colchicine, or
2 mM thymidine respectively, and the medium removed. The
cells were detached by trypsinisation, washed and resus-
pended in PBS. DNA was detected by staining with pro-
pidium iodide (PI) as described (Taylor, 1980). Briefly, a
stock solution of 2.5 mg ml-' PI in distilled water was
diluted 1:10 in 1% Triton X-100 in distilled water. This
solution was added to 2 ml of cell suspension to a final
concentration of 50jigml-' PI; nuclei were separated from
aggregates by filtration through 40jim nylon mesh and RNA
removed by digestion with 0.5 mg ml-' RNase A added
directly to the solution. DNA histograms were plotted using
a Beckton Dickinson FACSscan. Linear fluorescence data
were collected and analysed using the Consort 30 software
(Beckton Dickinson, Sunnyvale, CA, USA).
Protein kinase C assay
PKC activity was measured using a Gibco PKC assay system
(Gibco-Life Technologies Inc., Uxbridge, UK). Exponentially
growing cells were cultured in 80 cm2 Nunclon (Nunc, Kam-
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Figure 1 Effects of TNFx (10 ng ml) and/or PMA (1 ng ml) on
the growth of T47D cells. Cells grown in the presence of the
corresponding dilution of DMSO, the diluent of PMA, were not
signficantly different from the control (data not shown). Control
cells were grown in RPMI 1650/10% FCS. Data presented as
mean of triplicate cell counts ± S.D. (*P <0.05 compared to the
corresponding control group).
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Figure 2 3H-thymidine incorporation into total cellular extracts
(black bars) and purified DNA (open bars) of T47D cells. Cells
were grown in the absence (control) or presence of 10 ng ml
TNFa and pulse labelled with 10 m Ci ml thymidine as described
in Materials and methods.292 L. PUSZTAI et al.
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added to the medium at a concentration of 10 ngml-'. After
10 min exposure to these substances the medium was
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Figure 3 Effects of TNFVx and PMA on thymidine incorporation
by T47D cells. Cells were exposed to TNFa or PMA for 24 h.
The effects of corresponding dilutions of DMSO are also shown.
Data presented as mean of triplicate measurements ± S.D.
(*P <0.05 compared to corresponding control group).
Orn
a
ao
4.
* Pw@6M^A
1'- '*.
i ji %. 4
Ft. -. C@...
. ... .
I 0. I0 .20 .._ i 30.
Figure 5 PKC activity (represented by 32P incorporation into
specific substrate peptide) after 10 min of exposure to TNFx or
PMA (1Ong ml), was measured in total cellular extracts eluted
from a DEAE column. Substrate phosphorylation in the presence
of a PKC inhibitor (pseudosubstrate PKC129-36) is also shown.
Data points are the means of triplicate measurements. Error bars
represent ± S.D. (*P <0.05 compared to baseline PKC activity
detected in exponentially growing T47D cells).
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Figure 4 Flow cytometric profiles of (A) control, untreated, T47D cells; (B) cells synchronised by TNFa (10 ng ml); (C) colchicine
(50iLg ml); and (D) a single thymidine pulse (2 nM). The fluorescence intensity is plotted on the X-axis against the relative cell
number on the Y-axis. The gates for diploid, tetraploid, and S phase cells were set manually as indicated.
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30 min in fresh medium, cells were washed in ice-cold PBS.
Subsequently they were lysed with extraction buffer (20 mM
Tris, pH 7.5, 0.5 mM EDTA, 0.5 mM EGTA, 0.5% Triton
X-100, 25iLg ml1' aprotinin and leupeptin), and homo-
genised on ice with 10-15 strokes in a Dounce homogeniser.
The cell homogenate was incubated on ice for 30 min and
spun in a microcentrifuge to remove cellular debris. Partial
purification of PKC was performed on a DEAE cellulose
column (DE52, Whatman, Maidstone, UK) as recommended
by Gibco. 15 il of DEAE column eluate was tested for PKC
activity in a final volume of 50pl containing lipid prepara-
tion (Gibco) and a synthetic PKC substrate peptide Ac-MBP
(Gibco). The reaction was started by addition of ATPy-32
(10jILCitl-', 3000 Ci mmol 1, Amersham, UK). After 5 min
incubation at 30C, 25 ,ul of the reaction buffer was spotted
onto phosphocellulose paper. The phosphocellulose discs
were washed twice in 1% H3PO4 and rinsed with distilled
water before 32p incorporation was measured by liquid scin-
tillation counting. Assays containing the specific PKC in-
hibitor pseudosubstrate peptide, PKC19-36 (Gibco), served
as a control for nonspecific kinase activity. Each experiment
were performed in triplicate and repeated twice.
Results
Figures 1-7 shows data from single, representative experi-
ments. Similar data were obtained in replicate assays.
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Figure 7 H7 antagonises in a dose-dependent manner the in-
creased thymidine incorporation induced by PMA (I ngml). Cells
were exposed to PMA in the presence of various concentrations
of the PKC inhibitor, H7, for 4 h. Thymidine incorporation was
measured 20 h post-exposure. Data points represent the means of
triplicate measurements ± S.D. (*P <0.05 compared to corre-
sponding control group).
Cytostatic effect of TNFa on T47D cells
TNFoa inhibited the proliferation of T47D cells in a time- and
dose-dependent manner. After 7 days ofcontinuous exposure
to TNFa (1Ongml-'), the number of cells was reduced to
below 50% of that in the control (Figure 1). cell viability
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Figure 6 Effect of H7 on TNFx-induced inhibition of thymidine
incorporation. T47D cells were simultaneously exposed to in-
creasing concentrations of TNFx and H7 for 4 h. Thymidine
incorporation was detected 20 h post-exposure. Data presented as
mean of triplicate counts ± S.D. (*P <0.05 compared to corre-
sponding control group).
tested every 48 h was not impaired compared to the control.
3H-thymidine taken up by both, control and TNFa-exposed
T47D cells, are virtually entirely incorporated into purified
DNA (Figure 2). This has also been demonstrated by auto-
radiographic studies suggesting that thymidine incorporation
is a good indicator of DNA synthesis in T47D cells (Tamm
et al., 1991). Exposure to TNFa for 24 h inhibited thymidine
incorporation of the cells in a dose-dependent manner; 50%
inhibition being observed at 1 ng ml-' (Figure 3). Time-
course studies indicated that significant inhibition of
thymidine up-take could only be detected after a minimum of
18-20 h of exposure to TNFa, even when applied at
100 ng ml-' (data not shown). To determine whether either
continuous exposure was necessary to achieve inhibition, or
an initial exposure induced a delayed response, cells were
exposed to TNFa (10 ng ml-') for various time intervals
(0.5-10h), the medium changed (i.e. TNFa removed), and
thymidine incorporation measured at 6-10 h intervals during
a 60 h follow-up period. A minimum initial exposure of 4 h
was necessary to detect 50% inhibition of thymidine incor-
poration 18-24 h later. After 60h there was no significant
difference in thymidine incorporation between TNFx-treated
and control cells in this experiment (data not shown).
Cell cycle-specific arrest ofT47D cells by TNFa
After exposure to TNFa for 24 h, cells accumulated in the
GI phase of the cell cycle. The number of cells in G2/M
phase decreased from 16% to 9%, and in the S phase from
13% to 7% after exposure to TNFa. The number of cells in
GI increased from 60% to 72% (Figure 4). For comparison,
the effects of colchicine and single step thymidine syn-
chronisation on the DNA profile of T47D cells are also
shown in Figure 3. Colchicine blocks the cell cycle in the
mitotic phase while single step thymidine synchronisation
inhibits cells during the DNA synthetic phase.
Effect ofthe PKC agonist, PMA, on T47D cellproliferation
andDNA synthesis
In contrast to TNFa, PMA stimulates the proliferation of
T47 D cells (Figure 1). PMA also increased thymidine incor-
poration at least 2-fold at a concentration of 1 ngml-I
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(Figure 3). When cells were exposed to TNFa in the presence
of PMA, the PKC agonist was unable to counteract the
inhibitory effect of TNFa on cell growth (Figure 1) or
thymidine incorporation (data not shown).
TNFa and PMA transiently activates PKC in T47D cells
PKC activity peaked 5 min after TNFx treatment in total
cellular extracts, and declined to basal levels 30 min post-
treatment (Figure 5). A similar, but higher increase was
detected 5 min after exposure to PMA (Figure 5). The rate of
decline of the PMA- and TNFa-induced enzymatic activity
was similar. The baseline PKC activity (4000 ± 880 c.p.m.,
data not shown on figure) detected in cell extracts of
exponentially growing T47D cells, not exposed to either
TNFax nor PMA, was not significantly different from the
values obtained 30 min after TNFx/PMA treatment.
Effects ofthe enzyme-specific inhibitors H7, H8, W7 and
okadaic acid, on TNFa-induced inhibition ofthymidine
incorporation
Four hours of simultaneous exposure to H7 and TNFa failed
to impair the TNFx-induced inhibition of thymidine incor-
poration detected 20 h later (Figure 6). In contrast, H7
reversed, in a dose-dependent manner, the increase of thymi-
dine incorporation induced by PMA under similar conditions
(Figure 7). Complete inhibition of the PMA effect was
achieved at 50 1AM concentration. H7 administered alone for
4 h had no significant alteration in DNA synthesis at a
concentration below 100JAM (Figures 6 and 7). Similar
experiments performed with the enzyme inhibitors H8, W7,
and okadiac acid (OA) demonstrated that none of these
agents modified the delayed inhibitory effect of TNFoa on
thymidine incorporation by T47D cells (Figure 8a,b,c). H8
and OA administered alone did not alter basal thymidine
incorporation by these cells. However, W7 exerted a slight,
dose-dependent inhibition of thymidine up-take (Figure 8b).
Discussion
This report shows that whilst T47D cells are resistant to the
cytotoxic effects of TNFa, the growth of this breast cancer
cell line is reversibly arrested by this cytokine at the G/S
transition phase of the cell cycle. This cytostatic effect of
TNFa occurs only after a lag period of several hours. We
also investigated the involvement of various protein kinases
and phosphatases in the early (0-4 h) signal transduction
events induced by TNFa.
Previous studies addressing the cell cycle specificity of
TNFa action have concluded that this cytokine blocks the
progression of the cell cycle at the post-synthetic G2 or M
phases (Darzynkiewicz et al., 1984; Dealtry et al., 1987;
Muro et al., 1991). However, these studies employed cell lines
which responded to TNFa exposure with cell lysis. The pro-
liferation arrest reported in these cases was followed by cell
death within hours. In the present study we show that when
TNFa acts as a cytostatic rather than a cytotoxic agent it
synchronises cells at the GI phase. Our results, therefore,
support the hypothesis that the cytostatic and cytotoxic
effects ofTNFa may be mediated through different molecular
pathways (Ruggiero et al., 1987). It is interesting to note that
other cytokines with cytostatic action, including transforming
growth factor-P (TGFI), and interleukins 1 and 6, have also
been shown to exert a similar synchronising effect at the GI
phase on various cell lines (Belizario & Dinarello, 1991;
Paciotti & Tamarkin, 1991) suggesting that there may be a
common, cytokine-sensitive arrest point in the GI phase.
Despite extensive research, the signal transduction
mechanism induced by TNFa is not understood. Numerous
reports have implicated PKC in the actions of TNFa on
various cell lines. However, the role of PKC in TNFa-
induced biological responses is currently controversial. The
human colon cancer cell line, LoVo, is sensitive to the anti-
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Figure 8 Effect of various enzyme inhibitors on TNFa-induced
inhibition of thymidine incorporation. Cells were exposed to
TNFa in the presence of various concentrations of H8 a, W7 b,
or okadaic acid c respectively for 48 h. Thymidine incorporation
was measured 20 h post-exposure. Data presented as mean of
triplicate measurements ± s.d. (*P <0.05 compared to correspond-
ing control group).
proliferative effect ofTNFa, an effect which is blocked by the
PKC antagonist, H7 (Matsubara et al., 1990). PKC is also
involved in the action of TNFa on granulocyte-colony-
stimulating factor receptor (GCSF-R) expression (Elbaz et
al., 1991), progesterone production by rat follicles in vitro
(Sancho & Terranova, 1991) and expression of intercellular
adhesion molecule 1 (Lane et al., 1990).
However, a number of TNFa-induced responses appear to
be independent of PKC activation. TNFa enhances expres-
sion and secretion of group II phospholipase A2 by rat
astrocytes, and this response cannot be blocked by PKC
inhibitors (Oka & Arrita, 1991). TNFa-induced expression of
macrophage-colony-stimulating factor (MCSF) and inter-
leukin 6 (IL-6) by fibroblasts is also reported to be resistant
to PKC inhibitors (Mantovani et al., 1990 and 1991).
In this report we have demonstrated that TNFa rapidly
and transiently activates PKC in T47D cells. The functional
consequence ofPKC activation by TNFoc was further investi-
gated by monitoring the effect of this cytokine on the
thymidine incorporation in the presence of H7. PKC activa-
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tion is not likely to mediate the cytostatic effect of TNFx
because inhibition of PKC fails to block the TNFa-induced
drop in thymidine incorpation. Moreover, the stimulation of
PKC by PMA is associated with increased thymidine up-take
and cell proliferation. Both of these effects of PMA are
inhibited by H7. Thus, activation of PKC in T47D cells
appears to be involved in the initiation of DNA synthesis
and cell proliferation. Other molecular events simultaneously
induced by TNFa must overcome any putative, growth-
promoting activity of PKC.
Multiple signalling events induced by TNFa resulting in
distinct cellular responses have recently been reported. In
human leukaemia cell lines TNFa directly stimulates PKC,
but the TNFa-induced activation of the nuclear transcription
factor, NFKB, is not mediated by the activation of the
enzyme (Meichle et al., 1990; Feuillard et al., 1991). In view
ofthe recent discovery of two distinct TNF receptors (Brock-
haus et al., 1990) homologous in their extracellular domains
but, without any similarity in their intracellular domains it is
tempting to speculate that each receptor type may be
associated with distinct signalling pathways and biological
responses. Thus, PKC activation may be part of the signal
transduction for the type of TNF receptor not-involved in
the cytostatic effects of TNFa.
Nevertheless, it has to be remembered that PKC is not a
single enzyme, but a family of enzymes with at least seven
distinct molecular isoforms. These isoforms differ in their
activation requirements, substrate specificities, and subcel-
lular localisation. The functional relevance of this enzyme
heterogenity is not clear, and an intensive search for isozyme-
specific functions us currently under way. It has been sug-
gested that PKC inhibitors may also exhibit selective
specificity toward different forms of the enzyme (Bosca et al.,
1990). The results of studies using various inhibitors do not,
therefore, exclude the possibility that a putative, inhibitor-
resistant isoform of PKC is involved in TNFx-induced re-
sponses which appear to be PKC independent. Furthermore,
commercially available PKC inhibitors such as H7 are not
strictly enzyme-specific. H7 interacts with the ATP-binding
site of the catlytic domain of PKC which shares homology
with the ATP-binding site of numerous other ATP-binding
proteins. Thus, the possibility exists that such inhibitors may
interfere with other cellular functions, in addition to those
involving PKC activity and that this 'side-effect' may mask
any effect due to PKC inhibition.
To study the functional involvement of other signal trans-
duction pathways in the early events of TNFax signalling, cells
have been simultaneously exposed to TNFx and various
enzyme inhibitors for 4 h. The results presented here demon-
strate that neither cyclic-nucleotide-dependent nor cal-
modulin-dependent protein kinases are centrally involved in
the early signalling events leading to the inhibition of DNA
synthesis induced by TNFa. Furthermore, neither of the two
major protein phosphatases, PP1 and PP2B, appear to par-
ticipate in TNFa signal transduction leading to proliferation
arrest. Nevertheless, the reservations pointed out in the
previous paragraph should be borne in mind when interpret-
ing such data.
Taken together, the data presented in this paper indicate
that the cytostatic action of TNFa is exerted at the GI/S
transition of the cell cycle, via an intracellular mechanism
which may be largely independent of PKC, PKA, calmodulin
and the phosphatases PPI or PP2B.
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